Survey of the Efficacy and Safety of Short-term Enoxaparin Sodium Treatment in Patients after Abdominal Surgery

Enoxaparin sodium (EXP) is useful in preventing the development of venous thromboembolism (VTE) after abdominal surgery. In a phase III clinical study (EXP-P3-study), EXP was administered for 14 days after surgery; however, the dosing period recommendations in Japan remain unclear. In our hospital, EXP was administered for a period of 5 days, and the efficacy and safety of this treatment were retrospectively surveyed to assess whether short-term administration of EXP was useful in patients.